Brian Lundstrom
Chief Executive Officer presso Abvivo LLC
Profilo
Founder of Abvivo LLC, Brian Lundstrom is Chief Executive Officer at this company.
He is also Chief Business Officer of Open Monoclonal Technology, Inc.
He previously occupied the position of President of International Stem Cell Corp., Chief Executive Officer at Brexys and Chief Executive Officer at Windy Hill Medical, Inc. (a subsidiary of Brexys), Chief Business Officer & Vice President at Ligand Pharmaceuticals, Inc., Senior Vice President-Business Development for ACADIA Pharmaceuticals, Inc., Vice President-Business Development for SangStat Medical Corp., Vice President-Business Development at Genzyme Corp.
and Vice President-Corporate Development of Oxford GlycoSciences Plc.
Brian Lundstrom received an MBA from Copenhagen Business School, an MBA from Seattle University and a graduate degree from Technical University of Denmark.
Posizioni attive di Brian Lundstrom
Società | Posizione | Inizio |
---|---|---|
Open Monoclonal Technology, Inc.
Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2012 |
Abvivo LLC | Chief Executive Officer | 01/01/2019 |
Precedenti posizioni note di Brian Lundstrom
Società | Posizione | Fine |
---|---|---|
IMMUNOPRECISE ANTIBODIES LTD. | Director/Board Member | 30/11/2021 |
LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/06/2021 |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Director/Board Member | 01/01/2019 |
Windy Hill Medical, Inc.
Windy Hill Medical, Inc. Medical SpecialtiesHealth Technology Windy Hill Medical, Inc. manufactures and supplies medical devices. The firm focuses on the development of products to reduce the risk of breast cancer. The company was founded by Dr. Susan Love in 2004 and is headquartered in Laguna Hills, CA. | President | 28/05/2012 |
INTERNATIONAL STEM CELL CORPORATION | President | 11/05/2011 |
Formazione di Brian Lundstrom
Seattle University | Masters Business Admin |
Copenhagen Business School | Masters Business Admin |
Technical University of Denmark | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
INTERNATIONAL STEM CELL CORPORATION | Health Technology |
IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
Aziende private | 8 |
---|---|
SangStat Medical Corp. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Windy Hill Medical, Inc.
Windy Hill Medical, Inc. Medical SpecialtiesHealth Technology Windy Hill Medical, Inc. manufactures and supplies medical devices. The firm focuses on the development of products to reduce the risk of breast cancer. The company was founded by Dr. Susan Love in 2004 and is headquartered in Laguna Hills, CA. | Health Technology |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Open Monoclonal Technology, Inc.
Open Monoclonal Technology, Inc. BiotechnologyHealth Technology Open Monoclonal Technology, Inc. engages in the genetic engineering of animals for discovery of human therapeutic antibodies. The firm’s transgenic animal platforms include OmniRat, industry’s first human monoclonal antibody technology based on rats; OmniMouse, a transgenic mouse that complements OmniRat and expands epitope coverage and; OmniFlic, the first engineered rat with a fixed light chain for development of bispecific, fully human antibodies. The company was founded in by Roland Buelow 2007 and is headquartered in San Diego, CA. | Health Technology |
Brexys | |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Health Technology |
Abvivo LLC |